Ejection fraction (EF) measures how well the heart pumps blood. A normal ejection fraction is between 55% to 70%. A low ejection fraction can be a sign of heart failure. Ejection fraction (EF) ...
Is your heart functioning properly? There is a test which can measure this, which is often recommended by medical professionals. Ejection fraction (EF) is a measurement, expressed as a percentage, of ...
Heart failure is a heterogeneous syndrome. Approximately 30–50% of patients with heart failure have normal or near normal left ventricle function. Several epidemiological studies confirm that the ...
There may be a future for cardiac myosin inhibitors in heart failure with preserved ejection fraction (HFpEF), according to the proof-of-concept EMBARK-HFpEF trial. An established cardiac myosin ...
Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with HF across the ejection fraction (EF) spectrum.
Background Introduction of guideline-directed medical therapy (GDMT) has transformed the care of heart failure (HF) with ...
Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results